(2S,3R,4R,5S,6R)-2-(4-氯-3-(4-乙氧基苄基)苯基)-6-(羟甲基)四氢-2H-吡喃-3,4,5-三醇
Dapagliflozin (BMS-512148; 达格列净)
ChemLeader
产品编号:
CAS No.:
MDLNo:
分子式:
分子量:
选择规格
100 mg 250 mg 500 mg
产品库存
In-stock
目录价格
¥566.00
会员价格
产品库存
In-stock
目录价格
¥788.00
会员价格
产品库存
In-stock
目录价格
¥1488.00
会员价格
选择数量
- +
基本信息
中文名称(2S,3R,4R,5S,6R)-2-(4-氯-3-(4-乙氧基苄基)苯基)-6-(羟甲基)四氢-2H-吡喃-3,4,5-三醇
英文名称 Dapagliflozin (BMS-512148; 达格列净)
CAS号461432-26-8
分子式C21H25ClO6
分子量408.87
MDLMFCD13182359
外观White to off-white powder
储存条件Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years).
安全信息
产品详情

Dapagliflozin (formerly known as BMS-512148; trade names Farxiga in the US and Forxiga in the EU) is a potent and selective hSGLT2 (sodium-glucose transport proteins) inhibitor with anti-diabetic activity. It inhibits hSGLT2 with an EC50 of 1.1 nM, and exhibits1200-fold selectivity over hSGLT1.  Dapagliflozin inhibits subtype 2 of the sodium-glucose transport proteins (SGLT2) which are responsible for at least 90% of the glucose reabsorption in the kidney. Urine is the means by which blood glucose is expelled when this transporter mechanism is blocked.

相关文献
相关产品
抱歉,暂时没有相关产品
浏览记录
(2S,3R,4R,5S,6R)-2-(4-氯-3-(4-乙氧基苄基)苯基)-6-(羟甲基)四氢-2H-吡喃-3,4,5-三醇